FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

36417111000001108: Ezetimibe 10mg tablets (Aristo Pharma GmbH) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Dec 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111451201000001110 Ezetimibe 10mg tablets (Aristo Pharma GmbH) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111606601000001110 Ezetimibe 10mg tablets (Aristo Pharma Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Is a Product containing precisely ezetimibe 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has basis of strength substance Ezetimibe true Inferred relationship Existential restriction modifier 1
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has presentation strength numerator value 10 false Inferred relationship Existential restriction modifier 1
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has precise active ingredient Ezetimibe true Inferred relationship Existential restriction modifier 1
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has specific active ingredient Ezetimibe true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ezetimibe 10mg tablets (Aristo Pharma GmbH) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ezetimibe 10mg tablets (Aristo Pharma GmbH) 28 tablet 2 x 14 tablets Has AMP True Ezetimibe 10mg tablets (Aristo Pharma GmbH) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start